Literature DB >> 33238813

A multi-family cluster of COVID-19 associated with asymptomatic and pre-symptomatic transmission in Jixi City, Heilongjiang, China, 2020.

Hongyang Zhang1, Chengcheng Hong2,3, Qulu Zheng4, Pengzheng Zhou3, Yuliang Zhu1, Zhongkai Zhang5, Qifang Bi4, Ting Ma2,3.   

Abstract

We investigated a multi-family cluster of 22 cases in Jixi, where pre-symptomatic and asymptomatic transmission resulted in at least 41% of household infections of SARS-CoV-2. Our study illustrates the challenge of controlling COVID-19 due to the presence of asymptomatic and pre-symptomatic transmission even when extensive testing and contact tracing are conducted.

Entities:  

Keywords:  Asymptomatic transmission; COVID-19; cluster; contact tracing; household close contact; pre-symptomatic transmission

Mesh:

Year:  2020        PMID: 33238813      PMCID: PMC7717603          DOI: 10.1080/22221751.2020.1837015

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


Introduction

A sizeable proportion of COVID-19 cases are asymptomatic, though estimates vary greatly [1-4]. Estimated shorter serial interval of COVID-19 in comparison to its incubation period promotes pre-symptomatic spread of COVID-19 [5,6]. Modelling studies have suggested asymptomatic carriers of SARS-CoV-2 are major contributors in the propagation of COVID-19 [7]. Given the high risk of infection among household close contacts [8], asymptomatic transmission may complicate the control of household transmission. However, case reports showing asymptomatic transmission driving the spread of COVID-19 among household close contacts are still limited. Here we report a multi-family cluster of 22 cases in Jixi, a northern city of China, where pre-symptomatic and asymptomatic cases were key components of the transmission chains.

Materials and methods

The investigators interviewed patients with positive RT-PCR using a structured questionnaire and collected their demographic information, travelling history, and date of symptom onset within 14 days before confirmation. Questions on travel history to Wuhan city or Hubei province, contacts with febrile individuals, and visits to seafood markets were meant to capture other potential source of infection. Close contacts were individuals who lived with a PCR-confirmed case or interacted with a case within 1 meter from the case without any personal protections. All close contacts were quarantined in centralized facilities and were tested by RT-PCR. Positive cases with and without symptoms were immediately sent to hospitals for treatment after results were verified by provincial CDC. We defined those who were RT-PCR positive but showed no symptom or radiographic CT sign of infection throughout the course of infection as asymptomatic carriers. CT signs of SARS-CoV-2 infection included ground glass opacity, local patchy shadowing, bilateral patchy shadowing, and interstitial abnormality. All RT-PCR positive patients were isolated in the hospital for at least 14 days and were discharged once they stopped viral shedding. Those with negative results continued to be quarantined and were released once they had two negative test results, at least 24 hours apart (Appendix 1).

Results

On February 5 2020, the Jixi City Centre for Disease Control (Jixi CDC) in Heilongjiang province was notified of the first two cases (patient 2 and patient 3) diagnosed with COVID-19 in Jixi by a local hospital. After detailed epidemiological investigations of 93 close contacts, Jixi CDC identified a large cluster of 22 COVID-19 confirmed cases from 5 families, including 8 symptomatic and 14 asymptomatic cases. The outbreak first started and propagated in family A over a series of family gatherings and subsequently spread to four other families through pre-symptomatic or asymptomatic transmission (Figure 1(A)).
Figure 1.

Transmission chain of 22 COVID-19 cases associated with a multi-family cluster. (A) Family structure and transmission chains linking all 22 infected patients in the cluster. (B) Duration of exposure to index case, dates of symptom onset, duration of isolation, hospitalization for all close contacts of patients 14, 15, 16, and 19 outside of family A. Exposure history in family A were not presented because of heavily overlapping contact history between cases.

Transmission chain of 22 COVID-19 cases associated with a multi-family cluster. (A) Family structure and transmission chains linking all 22 infected patients in the cluster. (B) Duration of exposure to index case, dates of symptom onset, duration of isolation, hospitalization for all close contacts of patients 14, 15, 16, and 19 outside of family A. Exposure history in family A were not presented because of heavily overlapping contact history between cases. Family A Between January 22 and February 4, the 14-day period before case 2 was confirmed, Jixi CDC identified 25 people who participated in family A’s 30 gatherings (Appendix 1), and 13 of them (52%) were infected. Of the 13 infected family members, six were symptomatic (patients 1–6) and seven were asymptomatic (patients 7–13). However, the heavily overlapping contact history made it impossible to tease apart distinct transmission chains within family A (Appendix 2). Nevertheless, Jixi CDC considered patient 2 the most probable index case of the cluster after analysing possible transmission chains that resulted in the infection of the four index cases outside of family A. On January 27 and 28, the four index cases outside of family A shared meals with patients 3 and 8 from family A. Since patients 3 and 8 were their only possible source of infection, and patients 3 and 8 did not interact with any other cases with a travel history in family A before January 27 except for patient 2 (Figure 1), patient 2 was considered the most probable index case of the cluster. The four index patients in families B to E were most likely infected either by a pre-symptomatic case (patient 3) about five days before patient 3’s symptom onset or by an asymptomatic carrier (patient 8). Except for patient 15 who did not infect her close contacts, the other three cases subsequently infected five of their household close contacts. Out of the nine patients who were infected outside of family A, seven were asymptomatic (Figure 1(B)). Family B Patient 14 (50, female), the index case in family B, subsequently exposed four household members for 11 days after sharing meals with patients 3 and 8 on January 27 and 28. She felt eye discomfort on February 5 and was isolated four days after. Two of her household close contacts (patient 21 and 22) were tested positive, of whom patient 21 was asymptomatic and patient 22 had symptom onset on February 12, seven days after the index case (patient 14)’s symptom onset date. Patient 14 experienced viral shedding for at least 23 days. Family D Patient 16 (52, male), the index case in family D, infected his wife (patient 18) and daughter (patient 17) who all lived together between January 28 and February 5. They did not interact with any other known patients diagnosed with COVID-19. All three of them were asymptomatic. The other three contacts who were only exposed to the index case for an hour were not infected. Family E Patient 19 (50, female), the index case in family E, infected her husband (patient 20). The couple shared meals and lived together for 11 days from January 28 to February 7. They were both asymptomatic and had viral shedding for at least a month.

Discussion

In summary, this investigation identified a large cluster of 22 confirmed COVID-19 cases from 5 families, among whom 14 (64%) were asymptomatic. These asymptomatic cases in our study represent 61% (14 of 23) of asymptomatic patients in Jixi. Pre-symptomatic or asymptomatic transmission was responsible for at least 41% of infections whose transmission chains can be identified (9/22) (Figure 1(A)). Duration of viral shedding, defined as time of first positive RT-PCR test to hospital discharge after consecutively tested negative by RT–PCR twice, ranged from 9 days to 29 days, with a median of 17.5 days (range 15–26) for all symptomatic cases and 12.5 days (range 9–29) for asymptomatic cases. This cluster investigation has at least two limitations. First, due to the lack of serological testing and the complexity of this cluster, it is impossible to capture precise transmission chains and rule out the possibility that cases were infected from other unknown sources. Second, there was evidence that multiple introductions of imported cases could have caused infections among members in family A (patient 1 and possibly patients 12 and 13). This multi-family cluster presented additional evidence that asymptomatic and pre-asymptomatic cases can play a key role in silent household transmission of COVID-19. Extensively testing and isolating close contacts of confirmed cases reduced onward transmission. Early diagnosis and treatment may have also reduced duration of viral shedding [9]. Our investigation that was conducted outside of COVID-19 epicentres provided a snapshot of the possible scale of undetected asymptomatic transmission in epicentres of COVID-19 pandemic. Our results highlighted the important role of asymptomatic and pre-symptomatic cases in estimating the burden of COVID-19 pandemic. Extensive laboratory testing among close contacts can identify cases at early phase of infection and prevent onward transmission, and it is key to an effective COVID-19 surveillance programme. Click here for additional data file. Click here for additional data file.
  6 in total

1.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

Authors:  Ivan Fan-Ngai Hung; Kwok-Cheung Lung; Eugene Yuk-Keung Tso; Raymond Liu; Tom Wai-Hin Chung; Man-Yee Chu; Yuk-Yung Ng; Jenny Lo; Jacky Chan; Anthony Raymond Tam; Hoi-Ping Shum; Veronica Chan; Alan Ka-Lun Wu; Kit-Man Sin; Wai-Shing Leung; Wai-Lam Law; David Christopher Lung; Simon Sin; Pauline Yeung; Cyril Chik-Yan Yip; Ricky Ruiqi Zhang; Agnes Yim-Fong Fung; Erica Yuen-Wing Yan; Kit-Hang Leung; Jonathan Daniel Ip; Allen Wing-Ho Chu; Wan-Mui Chan; Anthony Chin-Ki Ng; Rodney Lee; Kitty Fung; Alwin Yeung; Tak-Chiu Wu; Johnny Wai-Man Chan; Wing-Wah Yan; Wai-Ming Chan; Jasper Fuk-Woo Chan; Albert Kwok-Wai Lie; Owen Tak-Yin Tsang; Vincent Chi-Chung Cheng; Tak-Lun Que; Chak-Sing Lau; Kwok-Hung Chan; Kelvin Kai-Wang To; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-05-10       Impact factor: 79.321

3.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.

Authors:  Qifang Bi; Yongsheng Wu; Shujiang Mei; Chenfei Ye; Xuan Zou; Zhen Zhang; Xiaojian Liu; Lan Wei; Shaun A Truelove; Tong Zhang; Wei Gao; Cong Cheng; Xiujuan Tang; Xiaoliang Wu; Yu Wu; Binbin Sun; Suli Huang; Yu Sun; Juncen Zhang; Ting Ma; Justin Lessler; Tiejian Feng
Journal:  Lancet Infect Dis       Date:  2020-04-27       Impact factor: 25.071

4.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).

Authors:  Ruiyun Li; Sen Pei; Bin Chen; Yimeng Song; Tao Zhang; Wan Yang; Jeffrey Shaman
Journal:  Science       Date:  2020-03-16       Impact factor: 47.728

5.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Takeshi Miyama; Ayako Suzuki; Sung-Mok Jung; Katsuma Hayashi; Ryo Kinoshita; Yichi Yang; Baoyin Yuan; Andrei R Akhmetzhanov; Natalie M Linton
Journal:  Int J Infect Dis       Date:  2020-03-14       Impact factor: 3.623

6.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

Authors:  Kenji Mizumoto; Katsushi Kagaya; Alexander Zarebski; Gerardo Chowell
Journal:  Euro Surveill       Date:  2020-03
  6 in total
  6 in total

1.  A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France).

Authors:  Dorine Decarreaux; Julie Sevila; Shirley Masse; Lisandru Capai; Toscane Fourié; Paola Mariela Saba Villarroel; Abdennour Amroun; Elif Nurtop; Matthieu Vareille; Marie Pouquet; Thierry Blanchon; Xavier de Lamballerie; Rémi Charrel; Alessandra Falchi
Journal:  Int J Environ Res Public Health       Date:  2022-02-10       Impact factor: 3.390

2.  Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.

Authors:  Abdulaziz Alhazmi; Edrous Alamer; Siddig Abdelwahab; Nizar Khamjan; Abdullah Hamami; Moayad Haddad; Majid Darraj; Anwar M Hashem; Abdullah Algaissi
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390

3.  Performance of formal smell testing and symptom screening for identifying SARS-CoV-2 infection.

Authors:  James W Keck; Matthew Bush; Robert Razick; Setareh Mohammadie; Joshua Musalia; Joel Hamm
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

4.  Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.

Authors:  Hendra Wibawa; Mohamad Saifudin Hakim; Ika Trisnawati; Riat El Khair; Rina Triasih; Kristy Iskandar; Nungki Anggorowati; Edwin Widyanto Daniwijaya; Endah Supriyati; Dwi Aris Agung Nugrahaningsih; Eko Budiono; Heni Retnowulan; Yunika Puspadewi; Ira Puspitawati; Osman Sianipar; Dwiki Afandy; Susan Simanjaya; William Widitjiarso; Dyah Ayu Puspitarani; Fadil Fahri; Untung Riawan; Aditya Rifqi Fauzi; Alvin Santoso Kalim; Nur Rahmi Ananda; Amalia Setyati; Dwikisworo Setyowireni; Ida Safitri Laksanawati; Eggi Arguni; Titik Nuryastuti; Tri Wibawa
Journal:  BMC Med Genomics       Date:  2021-06-01       Impact factor: 3.063

5.  Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource Savings.

Authors:  Francesc López Seguí; Jose Maria Navarrete Duran; Albert Tuldrà; Maria Sarquella; Boris Revollo; Josep Maria Llibre; Jordi Ara Del Rey; Oriol Estrada Cuxart; Roger Paredes Deirós; Guillem Hernández Guillamet; Bonaventura Clotet Sala; Josep Vidal Alaball; Patricia Such Faro
Journal:  Int J Environ Res Public Health       Date:  2021-07-03       Impact factor: 3.390

6.  A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona.

Authors:  Francesc López Seguí; Oriol Estrada Cuxart; Oriol Mitjà I Villar; Guillem Hernández Guillamet; Núria Prat Gil; Josep Maria Bonet; Mar Isnard Blanchar; Nemesio Moreno Millan; Ignacio Blanco; Marc Vilar Capella; Martí Català Sabaté; Anna Aran Solé; Josep Maria Argimon Pallàs; Bonaventura Clotet; Jordi Ara Del Rey
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.